key: cord-0310887-cy0pwuv8
authors: Freire, A. P. F.; Santos de Lira, F.; von Ah Morano, A. E.; Pereira, T.; Coelho Silva, M.-J.; Caseiro, A.; Destro Christofaro, D. G.; Marchioto, O.; Pires Dorneles, G.; Aurino Pinho, R.; Spolador de Alencar Silva, B.
title: ROLE OF BODY MASS AND PHYSICAL ACTIVITY IN AUTONOMIC FUNCTION MODULATION ON POST-COVID-19 CONDITION: AN OBSERVATIONAL SUBANALYSIS OF FIT-COVID STUDY
date: 2021-11-21
journal: nan
DOI: 10.1101/2021.11.17.21266473
sha: 1070f394cd02ffcc3815f1318a14372281e5e1c7
doc_id: 310887
cord_uid: cy0pwuv8

The harmful effects of coronavirus disease 2019 (COVID-19) can reach the autonomic nervous system (ANS) and endothelial function. Therefore, the detrimental multiorgan effects of COVID-19 could be induced by deregulations in ANS that may persist after the acute SARS-CoV-2 infection. Additionally, investigating the differences in ANS response in overweight/obese, and physically inactive participants who had COVID-19 compared to those who did not have the disease is necessary. The aim of the study was to analyze the autonomic function of young adults after mild-to-moderate infection with COVID-19 and to assess whether body mass index (BMI) and levels of physical activity modulates autonomic function in participants with and without COVID-19. Patients previously infected with COVID-19 and healthy controls were recruited for this cross-sectional observational study. A general anamnesis was taken and BMI and physical activity levels were assessed. The ANS was evaluated through heart rate variability. A total of 57 subjects were evaluated. Sympathetic nervous system activity in post-COVID-19 group was increased (stress index; p=0.0273). They also presented lower values of parasympathetic activity (p<0.05). Overweight/obese subjects in the post-COVID-19 group presented significantly lower parasympathetic activity and reduced global variability compared to non-obese in control group (p<0.05). Physically inactive subjects in post-COVID-19 group presented significantly higher sympathetic activity than active subjects in control group. Parasympathetic activity was significantly increased in physically active subjects in control group compared to the physically inactive post-COVID-19 group (p<0.05). COVID-19 promotes changes in the ANS of young adults, and these changes are modulated by Overweight/obesity and physical activity levels.

infection that has rapidly spread worldwide, reaching a pandemic level in 2020. reported in over 170 countries and has brought unprecedented morbidity, mortality, and disruption globally. 1, 2 Despite severe complications that may be caused by the virus, a significantly high number of individuals did not require intensive care and continue to present sequelae months after the COVID-19 diagnosis. 3 Although COVID-19 is primarily manifested as a respiratory disease, many studies have shown that it is a systemic infection involving multiple systems and affecting individuals of all ages. 2, 4 Initial studies showed that the harmful effects of COVID-19 could also reach the autonomic nervous system (ANS), even in non-hospitalized young individuals. Interestingly, detection of SARS-CoV-2 in carotid body of severe COVID-19 patients was previously reported, and its involvement may explain silent hypoxemia, a route of nervous system invasion and ANS deregulation. [5] [6] [7] It is hypothesized that autonomic dysfunction after COVID-19 infection could be mediated by the virus itself, 8 or even associated with the cytokine storm response, resulting in oxidative stress. These mediators can subsequently cross the blood-brain barrier, ultimately increasing the activation of the sympathetic nervous system (SNS). 6, 9 Furthermore, autonomic dysfunction has also been shown to be associated with COVID-19 severity and prognosis. 4 Further investigations to clarify the impact of COVID-19 on ANS are needed since the ANS plays a major role in regulating the body's homeostasis. Any dysfunction in this system can have detrimental effects on several physiological systems, including alterations in the cardiovascular system and the immune, hematological, and renal systems. 10 Additionally, a sympathetic overdrive has been identified as an independent predictor of mortality in several diseases. [11] [12] [13] Koopman et al., in an epidemiological study, observed that low cardiac autonomic modulation was associated with higher chances of mortality in individuals with low cardiovascular risk. 14 The autonomic imbalance may persist after acute SARS-CoV-2 infection, and the burden of several post-COVID-19 condition, including postural orthostatic tachycardia syndrome (POTS), dysautonomia, fatigue, cerebral hypoperfusion syndrome and impaired endothelial function, are associated with this condition independently of hospitalization. 6, 15, 16 A recent clinical case study reported strong benefits of invasive vagus nerve stimulation, such as relief of chest tightness and shortness of breath, in COVID-19 patients. 17 In fact, patients presenting postviral condition, such as myalgic encephalomyelitis, induced by several viruses manifest several alterations in ANS with harmful impact in the health and body homeostasis. [18] [19] [20] Thus, the ANS dysfunction after acute . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.17.21266473 doi: medRxiv preprint SARS-CoV-2 may be not necessarily new, but an old sequela observed in several post viral infectious episodes.

It is well established that other factors can directly affect autonomic function, such as obesity 21, 22 and levels of physical activity 23, 24 The present study adds novelty and relevant aspects to the literature since it (1) investigates cases after mild to moderate COVID-19 infection in young adults, a subgroup of patients who are often overlooked, that did not require intensive care, addressing the influence of obesity and physical activity after COVID-19 infection on the ANS (2) through the estimation of the heart rate variability (HRV), a reliable and noninvasive method. 26 To our knowledge, these data are not yet available in the literature.

Thus, the primary aim of the study was to analyze the autonomic function of young adults after mild to moderate infection by COVID-19. Second, we aimed to identify the influence of body mass index (BMI) and levels of physical activity on the autonomic function in these individuals, indexed to the HRV indicators.

The study was performed in accordance with ethical standards described by the Declaration of Helsinki. Additionally, all participants were informed of the study purpose and protocols and gave is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint written informed consent to the protocols. The Ethical Institutional Review Board approved the study (approval number: 38701820.0.0000.5402).

This is a cross-sectional observational study that is part of a broader research project: FIT-COVID Study. The study was previously registered at the Brazilian Clinical Trials Registry (https://ensaiosclinicos.gov.br/) (registration number: RBR-5dqvkv3). All reports followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. 27 Patients that were infected with COVID-19 were recruited to participate in the study through local media (TV, radio) and social media and via electronic access to participants' database of the infection (slight clinical symptoms, fever, or respiratory symptoms who were not admitted to the intensive care unit) were recruited after <180 days of diagnosis. 28 An age-matched healthy control group that was negative for SARS-CoV-2 was also recruited. To detect confirmed or probable previous SARS-CoV-2 infection, a lateral flow test for IgM and IgG antibodies was conducted using internal anti-SARS-CoV-2 Immunoglobulin G (IgG) and Immunoglobulin M (IgM) ELISA kits.

The exclusion criteria were as follows: (1) presence of any chronic noncommunicable diseases, (2) smokers, (3) history of drug use, (4) medications such as anti-inflammatory drugs, antibiotics, and other known for their impact over the ANS, and (5) patients that received intensive care.

A general anamnesis was taken, including sociodemographic characteristics and self-rated health and medical history (family comorbidities, cardiopulmonary symptoms, and medication use).

Symptoms that emerged during acute COVID-19 infection and persistent symptoms were also evaluated. Participants were also assessed regarding their BMI and physical activity level. Finally, blood pressure after 20 minutes of rest were also performed using auscultatory blood pressure measurement. 29 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ;  According to well established methods, BMI is the ratio of weight (kg) to height (m) squared.

To determine the weight, an electronic and previously calibrated scale (Kratos-Cas, São Paulo, SP, Brazil) was used with participants wearing light clothes, barefoot, and carrying no heavy objects.

Height was determined using a portable anthropometer (Kratos-Cas, São Paulo, SP, Brazil) after accurately adjusting participant posture before reading the fixed marker. 30 

The level of physical activity was measured using a triaxial accelerometer (GT3X+; ActiGraph, LLC, Pensacola, FL, USA). Participants were instructed to wear the accelerometer above the waist for seven consecutive days during waking hours. A minimum of four days with at least 10 h/day was defined as valid accelerometer data. Participants were instructed not to use the accelerometer while bathing or performing water activities. Moreover, every morning, a researcher sends a WhatsApp message reminding the participant to use the accelerometer.

Non-wear periods were defined as time intervals of at least 60 consecutive minutes of zero counts, with an activity interruption allowance of 0-100 counts/min lasting a maximum of 2 consecutive minutes. 31 Counts per minute were calculated using the sum of the total activity counts in the vertical axis divided by the valid days. Sedentary time was defined as values <100 counts/min, light physical activity as values between 100 and 2,019 counts/min, and moderate-vigorous physical activity as values >2,020 counts/min. Data were processed using the ActLife software (version 6.9.2, Pensacola, FL, USA). 32 Heart Rate Variability ANS function was measured through the HRV, a simple, dependable, inexpensive, and noninvasive method. 26 For testing, participants arrived at an outpatient clinic in a fasted state, having abstained from exercise, caffeine, and alcohol for at least 24 h before testing and ≥4 h after a snack or light meal. Testing took place in a quiet, environmentally controlled clinic, with an ambient temperature of ∼23 °C. Participants were asked to avoid consuming coffee, chocolate, or alcohol, taking medications the night before, and practicing vigorous physical activity 24 h before the assessment.

HRV analysis was undertaken in the morning to avoid circadian changes. 26 The heart rate was recorded beat-to-beat via a cardio-frequency meter (Polar RS800CX, Polar Electro, Kempele, Finland) at a 1 kHz sampling rate to assess cardiac autonomic modulation. With the chest strap and monitor, individuals were placed in a sitting position and remained at rest with spontaneous breathing for 25 min. HRV was performed on 256 consecutive intervals between successive heartbeats (RR intervals) from the most stable segment on the tachogram. Only series with <5% error were considered suitable for analysis. Kubios HRV® software (Biosignal Analysis is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. and Medical Image Group, Department of Physics, University of Kuopio, Finland) was used to complete the HRV analysis. 33, 34 The HRV was assessed in both the time and frequency domains. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.17.21266473 doi: medRxiv preprint

In our secondary analysis, the post-COVID-19 and control groups were categorized according to the BMI, dividing each group into eutrophic (<25 kg/m 2 ) and overweight/obese (≥25.0 kg/m 2 ).

Moreover, the groups were analyzed according to levels of physical activity, considering the subjects with <150 min of Moderate to Vigorous Physical Activity (MVPA) and subjects with ≥150 min of MVPA in each group. All secondary analyses were performed using the one-way analysis of variance or Kruskal-Wallis test according to data distribution. Effect sizes (ESs) were calculated for significant secondary comparisons and classified as negligible (<0.01), small (0.1-0.29), medium (0.3-0.49), and large (>0.5). 35 Correlational analysis between the number of reported symptoms in the post-COVID-19 group and the HRV index was performed using Pearson or Spearman test according to data distribution. Independent variables that presented statistical correlation were inserted in a model of linear regression analysis. P-values < 0.05 were considered significant.

For this study, 57 subjects were evaluated. Figure 1 shows the flow diagram of the number of individuals at each stage of the study. In the post COVID-19 group, nine subjects were women, and 11 were men. In the control group, 13 subjects were men, and 5 were women.

Patients in the post-COVID-19 group were evaluated 48.45±31.41 days after testing positive for COVID-19. These individuals were classified as mild (n = 15; 75%) and moderate (n = 5; 25%) cases. 36 A mean of 5.75 ± 2.61 symptoms (clinical and respiratory) was noted. The main symptoms reported and their respective prevalence were respiratory symptoms (n = 15; 75%), headache (n = 14; 70%), body pain (n = 14; 70%), anosmia (n = 10; 50%), ageusia (n = 9; 45%), fever (n = 6; 30%), and diarrhea (n = 5; 25%). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; Figure 1 . Flow diagram of the study.

No differences in sex distribution were observed between the groups (p = 0.3276). As indicated in Table 1 , the groups were uniformly distributed (p > 0.05) in terms of their descriptive characteristic data, except for light physical (p = 0.0444) and vigorous activities (p = 0.0380).

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; Table 1 . Sample characterization between groups. Data with normal distribution are expressed as mean and standard deviation and data with non-normal distribution as median and 25%-75% interquartile range.

Post-COVID-19 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; Table 2 . Comparisons between HRV indexes in the post-COVID-19 and control groups. Data with normal distribution are expressed as mean and standard deviation and data with non-normal distribution as median and 25%-75% interquartile range.

Post-COVID-19 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint In the secondary analysis, the post-COVID-19 and control groups were categorized into non-obese and overweight/obese, as shown in Table 3 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; Table 3 . Comparison of HRV indexes between the post-COVID-19 and control groups according to the BMI. Data with normal distribution are expressed as mean and standard deviation and data with non-normal distribution as median and 25%-75% interquartile range.

Post-COVID-19 

Comparisons between groups were also investigated with regard to the levels of physical activity, dividing the post-COVID-19 and control groups according to the MVPA (≥150 min and <150 min), as shown in Table 4 and is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; Table 4 . Comparisons of HRV indexes between the post-COVID-19 and control groups according to the physical activity levels. Data with normal distribution are expressed as mean and standard deviation and data with non-normal distribution as median and 25%-75% interquartile range. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; Table 5 . Comparison of HRV indexes between eutrophic and physically active subjects that presented with both overweight/obesity status and low levels of physical activity in both groups. Data are expressed as median and 25%-75% interquartile range.

Post-COVID-19 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ;  This result highlights the urgency of assessments regarding the progression of COVID-19 in patients who have recovered, even if they are young or had mild or moderate symptoms since an ANS dysregulation reveals a body homeostasis dysfunction and can predict cardiovascular and metabolic illnesses and are directly correlated with mortality in several diseases. 10, 43 It is known that COVID-19 can affect different organs and systems at different magnitudes. 6, 38 However, the impact of COVID-19 on the autonomic function of young individuals and its relationship with the BMI and physical activity level are not yet well established. Our findings revealed that patients who were overweight/obese in the post-COVID-19 group presented significantly lower parasympathetic activity and reduced global variability compared to that in eutrophic individuals in the control group (Table 3 and Figure 3 ). Autonomic dysfunction after COVID-19 can be aggravated in individuals with obesity since studies previously showed that reduced HRV is associated with obesity and inflammation. 44 The chronic low-grade inflammation caused by obesity, 45 combined with the cytokine storm response from the COVID-19 infection, 9 may promote an even worse autonomic dysregulation in overweight/obese patients.

Our study showed that in physically active participants, cardiac autonomic modulation levels were better when compared to that in their inactive peers, even in participants who had COVID-19.

These findings corroborate with substantial data showing that exercise promotes positive adaptations in HRV parameters in both control subjects and patients suffering from a variety of diseases. 23, 43 Similarly, both exercise training and physical activity habits improves heart rate variability parameters, the autonomic profile, arterial compliance as well as the baroreflex sensitivity in HIV+ patients, highlighting the impact of lifestyle habits to modulate ANS in viral conditions. 46, 47 Regular exercise can promote functional and structural changes in the central and peripheral mechanisms of the cardiovascular system to ensure proper blood perfusion and cardiac response according to metabolic demands. 48 There is a consistent body of evidence stating that exercise increases resting vagal activity and induces neuronal plasticity in central autonomic networks. It is suggested that these mechanisms are mainly related to improved control of the nucleus tractus solitarii, rostral ventrolateral medulla, and paraventricular nucleus of the hypothalamus. 48, 49 The previous autonomic adaptations in physically active individuals may explain the protective role of exercise observed after COVID-19 infection.

Post-viral conditions, such as chronic fatigue syndrome, are characterized by autonomic dysfunction that strongly interfere in the health quality and neurocognitive aspects of the patients.

Physical activity is a consistent predictor of the measure of autonomic function in chronic fatigue syndrome patients, predicting 45% of the variance in the resting HR; 36% of the variance in the sitting HR, 20% of the variance in standing HR, 20% of the variance in HR on tilt, and 56% of the variance in the SBP fall in phase II of the Valsalva maneuver. 50 is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint On the other hand, associations between low levels of moderate-to-high intensity physical activity patterns with resting HR and reduced HRV was previously reported in chronic fatigue syndrome patients, suggesting that reduction in physical activity can in part be explained by autonomic dysfunction but not fatigue severity. 51 Here, we reported that post COVID-19 patients had significantly low levels of vigorous physical activity that may be related to the imbalance in ANS dysfunction.

Additionally, this study revealed that the number of symptoms reported by patients during the course of the COVID-19 infection was associated with the HRV response. These data may be explained by the severity of the virus infection that will usually promote more severe symptoms, consequently affecting levels of inflammation and oxidative stress, 3, 8 mediating changes in the HRV. 52

The main limitations to our investigation were (1) the cross-sectional nature of the study and the small sample size. This is of particular concern because our primary outcome measure (HRV) is characterized by high interindividual variability. (2) Despite matching for age and BMI, groups were not similar regarding physical activity. The post-COVID-19 group was less active, probably due to the symptoms and indisposition related to the infection, which can generate a confounding bias. Therefore, longitudinal designs monitoring healthy young subjects recovering from SARS-CoV-2 infection are undoubtedly warranted to better understand the impact of the virus on ANS activity.

This study also presents several strengths. First, young subjects with post mild and moderate COVID-19 infection were investigated, a commonly overlooked population in recent studies. Second, to our knowledge, this is the first study to investigate the influence of the BMI and physical activity level on the ANS after COVID-19. Third, our results are of great clinical relevance since it shows the importance of screening and monitoring in young adults, especially those who are overweight/obesity or physically inactive. Finally, in our study, the practice of physical activity was measured using accelerometry, which provides more reliable information about the intensity of physical activity since self-reports may be susceptible to memory bias.

As practical applications of the present study, the importance of maintaining the BMI close to eutrophic levels and the consistent practice of physical activity is highlighted, even in the time of a pandemic where social isolation may be necessary (considering all precautions, for example, when performing outdoor physical activities).

Mild to moderate SARS-CoV-2 infection promotes changes in the ANS of young adults that persists one month after the acute phase of the disease. Additionally, the BMI and physical activity levels modulate the changes in the ANS after COVID-19 in different perspectives: excessive BMI accentuates the changes in the ANS whilst physical activity expresses a protective effect. Finally, the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.17.21266473 doi: medRxiv preprint severity of the symptomatology maintained after the SARS-CoV-2 infection may also have important consequences on the daily life activities and ability to perform physical activities, thus additionally contributing to the autonomic balance of these individuals. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted November 21, 2021. ; https://doi.org/10.1101/2021.11.17.21266473 doi: medRxiv preprint

A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. The FEBS journal

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)

Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?

Alteration of Autonomic Nervous System Is Associated With Severity and Outcomes in Patients With COVID-19

COVID-19 is getting on our nerves: sympathetic neural activity and haemodynamics in young adults recovering from SARS-CoV-2. The Journal of physiology

Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies

SARS-CoV-2 in carotid body

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists

Autonomic Nervous System Dysfunction

Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure

Assessment of human baroreflex function using carotid ultrasonography: what have we learnt? Acta physiologica

Relative burst amplitude of muscle sympathetic nerve activity is an indicator of altered sympathetic outflow in chronic anxiety

Heart rate

Long-COVID postural tachycardia syndrome: an American Autonomic Society statement

The Use of Non-invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience

Baroreceptor sensitivity and baroreceptor effectiveness index in cirrhosis: the relevance of hepatic venous pressure gradient. Liver international : official journal of the International Association for the Study of the Liver

Virus-induced airway obstruction and parasympathetic hyperresponsiveness in adult rats. American journal of respiratory and critical care medicine

Does the chronic fatigue syndrome involve the autonomic nervous system? The American journal of medicine

Cardiac Autonomic Neuropathy in Obesity, the Metabolic Syndrome and Prediabetes: A Narrative Review. Diabetes therapy : research, treatment and education of diabetes and related disorders

Aging, heart rate variability and metabolic impact of obesity

Individual responses to aerobic exercise: the role of the autonomic nervous system

Exercise and the autonomic nervous system

COVID-19: Surveillance, case investigation and epidemiological protocols 2020

Blood pressure measurement

Body Mass Index: Obesity, BMI, and Health: A Critical Review

Amount of time spent in sedentary behaviors in the United States

United States measured by accelerometer. Medicine and science in sports and exercise

Noções básicas de variabilidade da frequência cardíaca e sua aplicabilidade clínica

HRV in evaluating ANS function

Effect size estimates: current use, calculations, and interpretation

Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Assessment of Prolonged Physiological and Behavioral Changes Associated With COVID-19 Infection

Sympathetic activation: a potential link between comorbidities and COVID-19

Lifestyle Changes Related to Eating Habits

Status During COVID-19 Quarantine in Italy and Some European Countries. Frontiers in nutrition

Effects of COVID-19 home confinement on eating behavior: A review

The role of heart rate variability in sports physiology. Experimental and therapeutic medicine

Heart-rate variability: a biomarker to study the influence of nutrition on physiological and psychological health?

Obesity and C-reactive protein in various populations: a systematic review and meta-analysis. Obesity reviews : an official journal of the International Association for the Study of Obesity

Exercise training improves cardiovascular and autonomic profiles in HIV

Short-term aerobic training improves heart rate variability in men living with HIV: a pre-post pilot study. HIV research & clinical practice

Heart rate variability indexes as a marker of chronic adaptation in athletes: a systematic review

Exercise-induced neuronal plasticity in central autonomic networks: role in cardiovascular control

Does the Chronic Fatigue Syndrome Involve the Autonomic Nervous

We thank the National Council for Scientific and Technological Development (CNPq)-Brazil and the Coordination for the Improvement of Higher Education Personnel (CAPES)-Brazil (code 001). 

None of the authors has any conflicts of interests.